A Delphi study and International Consensus Recommendations: The use of bolus in the setting of postmastectomy radiation therapy for early breast cancer

Orit Kaidar-Person, Hannah M. Dahn, Alan M. Nichol, Liesbeth J. Boersma, Dirk de Ruysscher, Icro Meattini, Jean Philippe Pignol, Cynthia Aristei, Yazid Belkacemi, Dori Benjamin, Nuran Bese, Charlotte E. Coles, Pierfrancesco Franco, Alice Y. Ho, Sandra Hol, Reshma Jagsi, Anna M. Kirby, Livia Marrazzo, Gustavo N. Marta, Meena S. MoranHenrik D. Nissen, Vratislav Strnad, Yvonne Zissiadis, Philip M. Poortmans, Birgitte V. Offersen

Research output: Contribution to journalArticlepeer-review

Abstract

Bolus serves as a tissue equivalent material that shifts the 95–100% isodose line towards the skin and subcutaneous tissue. The need for bolus for all breast cancer patients planned for postmastectomy radiation therapy (PMRT) has been questioned. The work was initiated by the faculty of the European SocieTy for Radiotherapy & Oncology (ESTRO) breast cancer courses and represents a multidisciplinary international breast cancer expert collaboration to optimize PMRT. Due to the lack of randomised trials evaluating the benefits of bolus, we designed a stepwise project to evaluate the existing evidence about the use of bolus in the setting of PMRT to achieve an international consensus for the indications of bolus in PMRT, based on the Delphi method.

Original languageEnglish
Pages (from-to)115-121
Number of pages7
JournalRadiotherapy and Oncology
Volume164
DOIs
Publication statusPublished - Nov 2021

Keywords

  • Bolus
  • Breast cancer
  • Mastectomy
  • PMRT
  • Radiation therapy
  • Tissue compensator

Fingerprint

Dive into the research topics of 'A Delphi study and International Consensus Recommendations: The use of bolus in the setting of postmastectomy radiation therapy for early breast cancer'. Together they form a unique fingerprint.

Cite this